companydata.dkcompanydata.dk

Allarity Therapeutics Denmark ApS: Financial statements 2017

CVR: 38445928

Source: annual report 2017, Danish Business Authority

13/02/2017 – 31/12/2017

Allarity Therapeutics Denmark ApS (CVR 38445928) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -13,000 and a net result of DKK 339. Equity in the 2017 report amounted to DKK 50,339. The solvency ratio was 1.6%.

Gross Profit
DKK -13,000
Equity
DKK 50,339
Total Assets
DKK 3,239,044

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Allarity Therapeutics Denmark ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

Allarity Therapeutics Denmark ApS appoints new auditorFeb 13, 2017

As of February 13, 2017, EY Godkendt Revisionspartnerselskab has been appointed auditor of Allarity Therapeutics Denmark ApS.

Thomas Henrik Jensen joins the board of Allarity Therapeutics Denmark ApSFeb 13, 2017

As of February 13, 2017, Thomas Henrik Jensen has joined the board of directors of Allarity Therapeutics Denmark ApS.

Peter Buhl joins the board of Allarity Therapeutics Denmark ApSFeb 13, 2017

As of February 13, 2017, Peter Buhl has joined the board of directors of Allarity Therapeutics Denmark ApS.

Ulla Hald Buhl joins the board of Allarity Therapeutics Denmark ApSFeb 13, 2017

As of February 13, 2017, Ulla Hald Buhl has joined the board of directors of Allarity Therapeutics Denmark ApS.

Thomas Henrik Jensen joins Allarity Therapeutics Denmark ApS as directorFeb 13, 2017

As of February 13, 2017, Thomas Henrik Jensen is registered as director of Allarity Therapeutics Denmark ApS.

Allarity Therapeutics Denmark ApS is foundedFeb 13, 2017

Allarity Therapeutics Denmark ApS was founded on February 13, 2017.

About Allarity Therapeutics Denmark ApS

Allarity Therapeutics Denmark ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named OV-SPV2 ApS. The management consists of Steen Meier Knudsen and Jeffrey Stuart Ervin. The company is owned by Allarity Acquisition Subsidiary, Inc.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 174,000 the year before. Equity in the 2025 report amounted to DKK -2,476,000.

Source: annual report 2025, Danish Business Authority